Managing high blood pressure could prevent over 500,000 cardiovascular deaths annually, study finds

Expanding high blood pressure treatment to 80% of eligible adults in 20 middle-income countries could prevent over 518,000 cardiovascular deaths annually, according to preliminary modeling from Johns Hopkins University presented at the AHA Hypertension Scientific Sessions 2026. Currently, only one in five hypertensive adults in these nations has controlled blood pressure. Broader statin therapy and cancer screenings could prevent hundreds of thousands of additional deaths each year.

Hypertension control in middle-income countries

• ▪Only about one in five adults with hypertension across the 20 middle-income countries studied had controlled blood pressure below 140/90 mm Hg, according to the Johns Hopkins modeling analysis presented in October 2026.
• ▪The modeling study found that expanding hypertension control could prevent 223,282 annual cardiovascular deaths in upper-middle-income countries and 223,655 annual cardiovascular deaths in lower-middle-income countries.
• ▪A Johns Hopkins University School of Medicine modeling study presented at the AHA Hypertension Scientific Sessions 2026 found that expanding high blood pressure treatment to 80% of eligible adults in 20 middle-income countries could prevent 518,476 cardiovascular deaths annually.

Reducing deaths through statin use

• ▪In lower-middle-income countries analyzed by Johns Hopkins researchers, low rates of high cholesterol management and statin use present large opportunities for reducing cardiovascular mortality.
• ▪The Johns Hopkins modeling analysis estimated that expanding statin medication treatment for indicated high cholesterol to 80% coverage could prevent 340,682 cardiovascular deaths annually across 20 middle-income countries.

Hypertension treatment guidelines

• ▪Following recommendations in the American Heart Association 2025 guideline reduces mortality from high blood pressure and lowers risks of heart failure, stroke, and dementia.
• ▪The American Heart Association 2025 Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults sets a hypertension treatment goal of less than 130/80 mm Hg for adults.

Debatable claims

• ▪Middle-income countries should prioritize hypertension control over cancer screening
• ▪The 130/80 mm Hg hypertension target is overly restrictive for middle-income healthcare systems
• ▪Pharmaceutical treatment expansion is more effective than lifestyle modification in reducing cardiovascular deaths